Kanger in MoU with Zuellig

Kanger’s executive director Steven Kuah Choon Ching (pic) said in a press release that the company is pleased to be in this MOU to facilitate the distribution of Sinopharm’s Covid-19 vaccines in Malaysia.

PETALING JAYA: ACE Market-listed Kanger International Bhd has entered into a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for Covid-19 vaccine distribution in Malaysia.

Zuellig Pharma is one of the license holders authorised by the Malaysian Government to handle the distribution of vaccines.